APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Microarray-based Non-Invasive Prenatal Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Microarray-based Non-Invasive Prenatal Testing Industry Growth and Trends Forecast to 2032

Report ID 17418837012 May 2026102 pages

Choose your research edition.

Industry ResearchMicroarray-based Non-Invasive Prenatal Testing Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Microarray-based Non-Invasive Prenatal Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Microarray-based Non-Invasive Prenatal Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microarray-based Non-Invasive Prenatal Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Microarray-based Non-Invasive Prenatal Testing Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Microarray-based Non-Invasive Prenatal Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Microarray-based Non-Invasive Prenatal Testing market include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera and PerkinElmer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Microarray-based Non-Invasive Prenatal Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Microarray-based Non-Invasive Prenatal Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microarray-based Non-Invasive Prenatal Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microarray-based Non-Invasive Prenatal Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Microarray-based Non-Invasive Prenatal Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Microarray-based Non-Invasive Prenatal Testing Market by Company

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

Microarray-based Non-Invasive Prenatal Testing Segment by Type

Trisomy Detection

Microdeletion Syndromes

Other

Microarray-based Non-Invasive Prenatal Testing Segment by Application

Hospitals & Clinics

Independent Laboratories

Microarray-based Non-Invasive Prenatal Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microarray-based Non-Invasive Prenatal Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microarray-based Non-Invasive Prenatal Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microarray-based Non-Invasive Prenatal Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Microarray-based Non-Invasive Prenatal Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021-2026) Table 4. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2027-2032) Table 6. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2026) Table 9. Global Microarray-based Non-Invasive Prenatal Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2026) Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Microarray-based Non-Invasive Prenatal Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Microarray-based Non-Invasive Prenatal Testing Industry Trends Table 37. Microarray-based Non-Invasive Prenatal Testing Industry Drivers Table 38. Microarray-based Non-Invasive Prenatal Testing Industry Opportunities and Challenges Table 39. Microarray-based Non-Invasive Prenatal Testing Industry Restraints Table 40. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Company (2021-2026) Table 42. Global Microarray-based Non-Invasive Prenatal Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Microarray-based Non-Invasive Prenatal Testing Key Company Headquarters & Area Served Table 44. Global Microarray-based Non-Invasive Prenatal Testing Company, Product Type & Application Table 45. Global Microarray-based Non-Invasive Prenatal Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Microarray-based Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Agilent Technologies Company Information Table 49. Agilent Technologies Business Overview Table 50. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 52. Agilent Technologies Recent Development Table 53. Ariosa Diagnostics (Roche) Company Information Table 54. Ariosa Diagnostics (Roche) Business Overview Table 55. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 57. Ariosa Diagnostics (Roche) Recent Development Table 58. BGI Group Company Information Table 59. BGI Group Business Overview Table 60. BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. BGI Group Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 62. BGI Group Recent Development Table 63. Eurofins LifeCodexx GmbH Company Information Table 64. Eurofins LifeCodexx GmbH Business Overview Table 65. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 67. Eurofins LifeCodexx GmbH Recent Development Table 68. Illumina Company Information Table 69. Illumina Business Overview Table 70. Illumina Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Illumina Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 72. Illumina Recent Development Table 73. Laboratory Corporation of America Company Information Table 74. Laboratory Corporation of America Business Overview Table 75. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 77. Laboratory Corporation of America Recent Development Table 78. Myriad Genetics Company Information Table 79. Myriad Genetics Business Overview Table 80. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 82. Myriad Genetics Recent Development Table 83. Natera Company Information Table 84. Natera Business Overview Table 85. Natera Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Natera Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 87. Natera Recent Development Table 88. PerkinElmer Inc Company Information Table 89. PerkinElmer Inc Business Overview Table 90. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 92. PerkinElmer Inc Recent Development Table 93. Quest Diagnostics Company Information Table 94. Quest Diagnostics Business Overview Table 95. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 97. Quest Diagnostics Recent Development Table 98. Sequenom Company Information Table 99. Sequenom Business Overview Table 100. Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sequenom Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 102. Sequenom Recent Development Table 103. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2026) Table 106. North America Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Country (2027-2032) Table 108. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2026) Table 111. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2026) Table 116. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Country (2027-2032) Table 118. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2026) Table 121. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2026) Table 126. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Microarray-based Non-Invasive Prenatal Testing Product Image Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021-2032) Figure 7. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Trisomy Detection Image Figure 13. Global Trisomy Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Microdeletion Syndromes Image Figure 15. Global Microdeletion Syndromes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Microarray-based Non-Invasive Prenatal Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type 2025 VS 2032 Figure 20. North America Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032) Figure 21. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032) Figure 23. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032) Figure 25. Hospitals & Clinics Image Figure 26. Global Hospitals & Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Independent Laboratories Image Figure 28. Global Independent Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Microarray-based Non-Invasive Prenatal Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application 2025 VS 2032 Figure 31. North America Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032) Figure 32. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032) Figure 34. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Microarray-based Non-Invasive Prenatal Testing Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 41. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 44. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 47. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 50. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Trisomy Detection
  • Microdeletion Syndromes
  • Other
Applications
  • Hospitals & Clinics
  • Independent Laboratories
Companies covered
  • Agilent Technologies
  • Ariosa Diagnostics (Roche)
  • BGI Group
  • Eurofins LifeCodexx GmbH
  • Illumina
  • Laboratory Corporation of America
  • Myriad Genetics
  • Natera
  • PerkinElmer Inc
  • Quest Diagnostics
  • Sequenom

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  8. 1.5.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (2021-2032)
2 Microarray-based Non-Invasive Prenatal Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Trisomy Detection
  3. 2.1.2 Microdeletion Syndromes
  4. 2.1.3 Other
  5. 2.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  6. 2.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Regions
  10. 2.3.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Type (2021-2026)
3 Microarray-based Non-Invasive Prenatal Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals & Clinics
  3. 3.1.2 Independent Laboratories
  4. 3.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  5. 3.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Regions
  9. 3.3.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Microarray-based Non-Invasive Prenatal Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends
  2. 4.2 Microarray-based Non-Invasive Prenatal Testing Industry Drivers
  3. 4.3 Microarray-based Non-Invasive Prenatal Testing Industry Opportunities and Challenges
  4. 4.4 Microarray-based Non-Invasive Prenatal Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Microarray-based Non-Invasive Prenatal Testing Revenue (2021-2026)
  2. 5.2 Global Microarray-based Non-Invasive Prenatal Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Microarray-based Non-Invasive Prenatal Testing Key Company Headquarters & Area Served
  4. 5.4 Global Microarray-based Non-Invasive Prenatal Testing Company, Product Type & Application
  5. 5.5 Global Microarray-based Non-Invasive Prenatal Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Microarray-based Non-Invasive Prenatal Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Microarray-based Non-Invasive Prenatal Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Microarray-based Non-Invasive Prenatal Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Agilent Technologies
  2. 6.1.1 Agilent Technologies Company Information
  3. 6.1.2 Agilent Technologies Business Overview
  4. 6.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  6. 6.1.5 Agilent Technologies Recent Developments
  7. 6.2 Ariosa Diagnostics (Roche)
  8. 6.2.1 Ariosa Diagnostics (Roche) Company Information
  9. 6.2.2 Ariosa Diagnostics (Roche) Business Overview
  10. 6.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  12. 6.2.5 Ariosa Diagnostics (Roche) Recent Developments
  13. 6.3 BGI Group
  14. 6.3.1 BGI Group Company Information
  15. 6.3.2 BGI Group Business Overview
  16. 6.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  18. 6.3.5 BGI Group Recent Developments
  19. 6.4 Eurofins LifeCodexx GmbH
  20. 6.4.1 Eurofins LifeCodexx GmbH Company Information
  21. 6.4.2 Eurofins LifeCodexx GmbH Business Overview
  22. 6.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  24. 6.4.5 Eurofins LifeCodexx GmbH Recent Developments
  25. 6.5 Illumina
  26. 6.5.1 Illumina Company Information
  27. 6.5.2 Illumina Business Overview
  28. 6.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  30. 6.5.5 Illumina Recent Developments
  31. 6.6 Laboratory Corporation of America
  32. 6.6.1 Laboratory Corporation of America Company Information
  33. 6.6.2 Laboratory Corporation of America Business Overview
  34. 6.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  36. 6.6.5 Laboratory Corporation of America Recent Developments
  37. 6.7 Myriad Genetics
  38. 6.7.1 Myriad Genetics Company Information
  39. 6.7.2 Myriad Genetics Business Overview
  40. 6.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  42. 6.7.5 Myriad Genetics Recent Developments
  43. 6.8 Natera
  44. 6.8.1 Natera Company Information
  45. 6.8.2 Natera Business Overview
  46. 6.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  48. 6.8.5 Natera Recent Developments
  49. 6.9 PerkinElmer Inc
  50. 6.9.1 PerkinElmer Inc Company Information
  51. 6.9.2 PerkinElmer Inc Business Overview
  52. 6.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  54. 6.9.5 PerkinElmer Inc Recent Developments
  55. 6.10 Quest Diagnostics
  56. 6.10.1 Quest Diagnostics Company Information
  57. 6.10.2 Quest Diagnostics Business Overview
  58. 6.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  60. 6.10.5 Quest Diagnostics Recent Developments
  61. 6.11 Sequenom
  62. 6.11.1 Sequenom Company Information
  63. 6.11.2 Sequenom Business Overview
  64. 6.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  66. 6.11.5 Sequenom Recent Developments
7 North America
  1. 7.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  3. 7.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  3. 10.3 South America Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst